Microorganisms
were screened for the ability to modify the squalene synthase inhibitor squalestatin 1. Biotransformation of 1 by two actinomycetes, SI5106 and SI5138, yielded three products hydroxylated on the 4,6-dimethyl-oct-2-enoyl side chain either at the 6 position (5) or 7 position (4 two diastereoisomers), and lacking the acetyl ester from the C-l side chain. Manystrains were found to hydrolyse the 4,6-dimethyl-oct-2-enoyl or acetyl esters to yield squalestatins 2 or 3.
The 3-methyl ester (6) of 1 was obtained using Fusarium sp. F13945. This fungus also produced a farnesoic acid derivative, possibly in response to inhibition of its squalene synthase by 1. The biotransformation products of 1 all retained potent squalene synthase inhibitory activity. As part of a programme to explore the effect of structural modifications on the biological activities of these compounds, microorganisms were screened for the ability to convert squalestatins to novel derivatives. This paper reports the microbial modification of 1 via hydroxylation of the 4,6-dimethyl-oct-2-enoyl side chain, and hydrolysis of the two ester functionalities. 2,3-Dihydrofarnesoic acid was also produced by a Fusarium sp. F13945 only in the presence of squalestatin 1.
Materials and Methods Materials
Compound1 was isolated from large scale cultures of Phomasp. and the tri-potassium salt was prepared as described elsewhere6).
Microorganisms
Microorganismswere obtained from various culture collections or were isolated from environmental samples. The actinomycete SI5138 which produced 4 and 5 was deposited as NCIMB40434.
Culture Conditions
For biotransformation screening, a two stage fermenation was employed.Actinomyceteseed cultures were APR. 1995 systems were employed each using a 5 /mi Spherisorb C6 column (150x4.6mm) with UV detection at 210nm. Substrate utilisation, and production of the desacetyl derivative, was measuredusing a mobile phase of acetonitrile-water (1 : 1) acidified with H2SO4 (0.015% v/v) at a flow rate of 3 ml/minute. Moredetailed analyses were carried out using a linear gradient from 0 to 50% acetonitrile in water acidified with H2SO4(0.015% v/v) over 15 minutes. The acetonitrile content was held at 50% for a further 10 minutes (flow rate 1 ml/minute).
Mass Spectrometry
MSanalysis was carried out using negative ion FAB with a glycerol-thioglycerol (1 : 1) matrix. The source was fitted to a Finnigan Mat 8400 mass spectrometer operating at a resolving power of 1000. Xenon was used as the FABgas and the atom gun was operated at 9kV and 1mA. Under the above conditions this class of compoundsafforded strong [M-H]~molecular ions coupled with structurally informative fragment ions.
NMR Spectroscopy
NMR spectra were recorded in CD3OD on a Bruker AM500instrument. Chemical shifts are reported in ppm referenced to CHD2OD(3.31 ppm) for XH and CD3OD (48.9) for 13C as internal standards. Coupling constants are given in Hz (±0.5). The number of protons carried by each carbon was determined using DEPT.
Isolation of Products
Biotransformation reactions were carried out as summarised in Table 1 Actinomycete SI5138: Cultures grown in both media were pooled, an equal volume ofMeCNadded (3.2 liters) and the mixture acidified with H2SO4(12.8ml). Cells were removed by centrifugation (5,000 x g, 30 minutes) and discarded and the MeCNremoved from the supernatant under vacuum.The aqueousresidue was passed through a column of Amberlite XAD16(22x 3.6cm, Rohmand Haas) which was then washed sequentially with water (200ml), disodium edetate (1% w/v, 200ml) and water (200ml). Adsorbed components were eluted with acetone-water (6 : 4). The eluate was diluted with an equal volume of water, adjusted to pH 2 with H2SO4 and pumped onto an HPLCcolumn of Spherisorb S5 Similar treatment of the 3 liters fraction from P40 yielded 12mg of7. Solutes were recovered from column eluates by pumping a 1 : 1 dilution of the sample in water through a cleaned, water-equilibrated column of Spherisorb S5ODS2(25x2.1cm). The column was washed with water until free of H2SO4and adsorbed material was eluted with MeCN-H2O (9: 1) or (7:3). MeCN was removed from the eluate by evaporation and the concentrate was either lyophilised to give final product or subjected to further chromatography.
Squalene Synthase Assays
Inhibition of rat liver squalene synthase was measured using procedures described in detail elsewhere1>8). A similar procedure using a microsomal preparation derived from Candida albicans ATCC10231 was used to measure inhibition of fungal squalene synthase.
In Vivo Cholesterol Lowering Activity Cholesterol lowering activity was measured in marmosets using procedures previously described3). with an authentic standard but in order to confirm identification, the product was isolated from a culture of Streptomyces rimosus NRRL 2455. The MS and NMR data were identical with those for authentic material2).
Biotransformation of 1 to 3
Hydrolysis of the 4,6-dimethyl-oct-2-enoyl ester of 1, to yield 3, was observed in cultures of 1 actinomycete, 4 fungi and 9 bacteria. Presumptive identification of the product was based on gradient HPLCcomparison with an authentic standard but in one case the material produced by biotransformation with Streptomyces lavendulae was isolated and its identity confirmed by comparison (MS, NMR)with authentic material2*.
Hydroxylated Derivatives of 2 Produced by Actinomycetes S15106 and S15138 Actinomycetes SI5106 and SI5138 hydrolysed the acetyl ester on the C-l side-chain of 1 converting 50~80% to product 2. A small proportion (<5%) of the substrate was additionally modified by SI 5106 to two new products. The mass spectra of these (Fig. 3) showed an intense (M-H)~ion at mjz 663 with characteristic fragment ions at m/z 619, 495, 433 and 185 which suggested that, in addition to the loss of the acetyl group, hydroxylation of the 4,6-dimethyl-oct-2-enoyl ester side chain had taken place. Examination of the 1H NMR spectra of these compounds (Table 2) showed the replacement of the triplet, assigned to the 31 position, by a doublet. Each also contained a signal consistent with the presence of a new CH-Ogroup. These data established the point of hydroxylation as C-30, the two compounds being the stereo-isomers at this position (4).
Biotransformations
with SI5138 produced larger amounts of 4, together with a small amount of a further novel squalestatin. The mass spectrum of this compound was essentially the same as that for 4 (Fig. 3) . The *H NMRspectrum (Table 2) showed the replacement of the doublet, assigned to the 33 position, by a singlet. These data established the point of hydroxylation as C-29. The configuration at the newly hydroxylated carbon has not been determined.
Products Isolated from Cultures of Fusarium sp.
F13945
A culture of Fusarium sp. F13945 converted 1 to a product found by HPLC-MS to have a molecular weight 14 mass units greater than the free acid of 1 and Rt typical of a mono-methyl ester of 1. Following isolation, this biotransformation product was shown by NMRand MS, to be identical to a synthetic sample of 69). A 4 liters culture grown to provide sufficient material for isolation and characterisation of this biotransformation product yielded an additional compound. The NMRspectra (*H, 13C and DEPT) of this material are consistent with structure 7 (Fig. 1) . The 13C spectrum was assigned by comparison with a range of related compounds10*. (ll-CH3), 16.0 (7-CH3).
Compound 7 was found only in cultures fed with 1. It is not squalestatin-related so its production appears to be a response ofFusarium to the presence of 1. The most likely explanation is that inhibiting squalene synthase caused a build up of its substrate, farnesyl pyrophosphate (FPP) , which Fusarium converted to 7. Reports of experiments with radiolabelled precursors show that rat hepatocytes3), Hep G2 cells5) and mice5) exposed to squalene synthase inhibitors also accumulate FPP and related metabolites.
Biological Activity of the Compounds Isolated
The concentration of compounds 4~6 causing 50% inhibition of squalene synthase activity (IC50) was comparable with squalestatins 1~3 for both rat and Candida enzymes (Table 3) . 4, as a mixture of isomers (78 : 22) was evaluated in single dose lipid lowering studies in marmosets. At 1 mg/kg iv 4 had no significant effect on serum cholesterol. A dose of 8mg/kg iv produced a significant lowering of lipid levels (44%) 2 days after dosing, which returned to baseline levels 7 days after dosing.
